Agencia Española de Medicamentos y Productos Sanitarios. AEMPS (2022) Ficha técnica Nolotil 575 mg cápsulas duras. https://cima.aemps.es/cima/dochtml/ft/47633/FT_47633.html. Accessed 6 Jun 2024

Ibáñez L, Vidal X, Ballarín E, Laporte JR (2005) Agranulocytosis associated with dipyrone (metamizol). Eur J Clin Pharmacol 60(11):821–829

Article  PubMed  Google Scholar 

Huber M, Andersohn F, Sarganas G, Bronder E, Klimpel A, Thomae M et al (2015) Metamizole-induced agranulocytosis revisited: results from the prospective Berlin Case-Control Surveillance Study. Eur J Clin Pharmacol 71(2):219–227

Article  CAS  PubMed  Google Scholar 

Risks of agranulocytosis and aplastic anemia (1986) A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study. JAMA 256(13):1749–1757

Article  Google Scholar 

Hedenmalm K, Spigset O (2002) Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Eur J Clin Pharmacol 58(4):265–274

Article  CAS  PubMed  Google Scholar 

Hoffmann F, Bantel C, Jobski K (2020) Agranulocytosis attributed to metamizole: an analysis of spontaneous reports in EudraVigilance 1985–2017. Basic Clin Pharmacol Toxicol 126(2):116–125

Article  CAS  PubMed  Google Scholar 

Andrès E, Mourot-Cottet R, Maloisel F, Séverac F, Keller O, Vogel T et al (2017) Idiosyncratic drug-induced neutropenia & agranulocytosis. QJM Mon J Assoc Physicians 110(5):299–305

Google Scholar 

Andersohn F, Konzen C, Garbe E (2007) Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med 146(9):657–665

Article  PubMed  Google Scholar 

Rudin D, Lanzilotto A, Bachmann F, Housecroft CE, Constable EC, Drewe J et al (2019) Non-immunological toxicological mechanisms of metamizole-associated neutropenia in HL60 cells. Biochem Pharmacol 163:345–356

Article  CAS  PubMed  Google Scholar 

Rudin D, Roos NJ, Duthaler U, Krähenbühl S (2019) Toxicity of metamizole on differentiating HL60 cells and human neutrophil granulocytes. Toxicology 1(426):152254

Article  Google Scholar 

Jasiecka A, Maślanka T, Jaroszewski JJ (2014) Pharmacological characteristics of metamizole. Pol J Vet Sci 17(1):207–214

Article  CAS  PubMed  Google Scholar 

Rattay B, Benndorf RA (2021) Drug-induced idiosyncratic agranulocytosis - infrequent but dangerous. Front Pharmacol 12:727717

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andrès E, Zimmer J, Affenberger S, Federici L, Alt M, Maloisel F (2006) Idiosyncratic drug-induced agranulocytosis: update of an old disorder. Eur J Intern Med 17(8):529–535

Article  PubMed  Google Scholar 

Klose S, Pflock R, König IR, Linder R, Schwaninger M (2020) Metamizole and the risk of drug-induced agranulocytosis and neutropenia in statutory health insurance data. Naunyn Schmiedebergs Arch Pharmacol 393(4):681–690

Article  CAS  PubMed  Google Scholar 

Agencia Española de Medicamentos y Productos Sanitarios. AEMPS (2018) Fentanilo de liberación inmediata: importancia de respetar las condiciones de uso autorizadas. https://www.aemps.gob.es/informa/notasinformativas/medicamentosusohumano-3/seguridad-1/2018/ni-muh_fv_5-2017-fentanilo/. Accessed 6 Jun 2024

Maciá-Martínez MA, Gil M, Huerta C, Martín-Merino E, Álvarez A, Bryant V et al (2020) Base de Datos para la Investigación Farmacoepidemiológica en Atención Primaria (BIFAP): a data resource for pharmacoepidemiology in Spain. Pharmacoepidemiol Drug Saf 29(10):1236–1245

Article  PubMed  Google Scholar 

Gardarsdottir H, Souverein PC, Egberts TCG, Heerdink ER (2010) Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap length. J Clin Epidemiol 63(4):422–427

Article  PubMed  Google Scholar 

Ibáñez L, Vidal X, Ballarín E, Laporte JR (2005) Population-based drug-induced agranulocytosis. Arch Intern Med 165(8):869–874

Article  PubMed  Google Scholar 

Gerhard T (2008) Bias: considerations for research practice. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm 65(22):2159–2168

Article  Google Scholar 

Coates TD (2022) Drug-induced neutropenia and agranulocytosis - UpToDate. https://sso.uptodate.com/contents/drug-induced-neutropenia-and-agranulocytosis?search=agranulocitosis%20por%20medicamentos&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1. Accessed 12 Jul 2023

Navarro-Martínez R, Chover-Sierra E, Cauli O (2016) Non-chemotherapy drug-induced agranulocytosis in a tertiary hospital. Hum Exp Toxicol 35(3):244–250

Article  PubMed  Google Scholar 

Pick AM, Nystrom KK (2014) Nonchemotherapy drug-induced neutropenia and agranulocytosis: could medications be the culprit? J Pharm Pract 27(5):447–452

Article  PubMed  Google Scholar 

Kaufman DW, Kelly JP, Levy M, Shapiro S (1993) The drug etiology of agranulocytosis: an update of the international agranulocytosis and aplastic anemia study. Pharmacoepidemiol Drug Saf 2(S7):S25–S29

Article  Google Scholar 

Van Staa TP, Boulton F, Cooper C, Hagenbeek A, Inskip H, Leufkens HGM (2003) Neutropenia and agranulocytosis in England and Wales: incidence and risk factors. Am J Hematol 72(4):248–254

Article  PubMed  Google Scholar 

Longo D, Fauci A, Kasper D, Hauser S, Jameson J, Loscalzo J (2011) Harrison’s principles of internal medicine, 18th edn. McGraw Hill Professional

van der Klauw MM, Goudsmit R, Halie MR, van’t Veer MB, Herings RM, Wilson JH, et al (1999) A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med. 159(4):369–74

Article  PubMed  Google Scholar 

Hamerschlak N, Maluf E, Biasi Cavalcanti A, Avezum Júnior A, Eluf-Neto J, Passeto Falcão R et al (2008) Incidence and risk factors for agranulocytosis in Latin American countries–the Latin Study: a multicenter study. Eur J Clin Pharmacol 64(9):921–929

Article  PubMed  Google Scholar 

Shapiro S, Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Thamprasit T et al (199AD) Agranulocytosis in Bangkok Thailand a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group. Am J Trop Med Hyg 60(4):573–7

Article  CAS  PubMed  Google Scholar 

Blaser LS, Tramonti A, Egger P, Haschke M, Krähenbühl S, Rätz Bravo AE (2015) Hematological safety of metamizole: retrospective analysis of WHO and Swiss spontaneous safety reports. Eur J Clin Pharmacol 71(2):209–217

Article  CAS  PubMed  Google Scholar 

Fieler M, Eich C, Becke K, Badelt G, Leimkühler K, Messroghli L et al (2015) Metamizole for postoperative pain therapy in 1177 children: a prospective, multicentre, observational, postauthorisation safety study. Eur J Anaesthesiol 32(12):839–843

Article  CAS  PubMed  Google Scholar 

Andrade S, Bartels DB, Lange R, Sandford L, Gurwitz J (2016) Safety of metamizole: a systematic review of the literature. J Clin Pharm Ther 41(5):459–477

Article  CAS  PubMed  Google Scholar 

Kaufman DW, Kelly JP, Jurgelon JM, Anderson T, Issaragrisil S, Wiholm BE et al (1996) Drugs in the aetiology of agranulocytosis and aplastic anaemia. Eur J Haematol Suppl 60:23–30

Article  CAS  PubMed  Google Scholar